InoRx is a next-generation CRO built to accelerate clinical development for biotech and pharmaceutical sponsors worldwide. Backed by the SRM Group, a $1.4 billion global enterprise with deep roots in healthcare and research, InoRx combines direct access to approximately 500,000 patients through the SRM hospital system with a network of nearly 500 clinical sites, providing sponsors with exceptional reach and access to accelerate clinical development.
With deep clinical expertise, senior-level attention, and end-to-end capabilities spanning trial design and feasibility through site start-up, clinical execution, data management, biostatistics, pharmacovigilance, laboratory services, and medical writing, InoRx helps sponsors simplify trials, accelerate enrollment, and bring innovative therapies to patients sooner.
Direct affiliation with SRM’s extensive hospital network provides access to large and diverse patient populations across multiple therapeutic areas. This enables faster recruitment, earlier proof-of-concept, and timely execution—critical milestones for emerging biotech programs.
InoRx was purpose-built for small and mid-size sponsors, providing senior leadership attention, flexible engagement, and tailored solutions that align with the urgency of biotech development.
With SRM’s decades-long reputation in healthcare, education, and research, InoRx delivers credibility, stability, and experienced clinical oversight—ensuring trials meet global standards with uncompromising quality.
Combine real-world data, physician insights, and predictive modeling to identify patients with precision and accelerate recruitment
Streamlined regulatory and contractual workflows to launch trials in weeks, not months
Expert protocol development and study reporting with scientific precision
End-to-end project management ensuring compliance, patient safety, faster patient enrollment, and on-time delivery
Deliver clean, compliant data and rapid, reliable analyses that accelerate decisions and drive regulatory success
SRM hospitals, 500+ rigorously vetted sites, 800+ clinicians, and 200+ Primary Investigators, and large patient populations across diverse therapeutic areas to accelerate enrollment
The resources and clinical expertise to get underperforming studies back on track fast.
We help plan smarter clinical trials by focusing on patients, feasibility, and enrollment strategies that reduce risk and keep studies on track.
SRM’s molecular diagnostic center includes a Biosafety Level 3 facility with NABL accreditation performing advanced viral PCR, and has participated as a site in major vaccine trials including COVAXIN.
SRM’s clinical and diagnostic services include pulmonary function testing, bronchoscopy, automated TB and infectious respiratory disease diagnostics—supporting studies in COPD, asthma, TB, and post-COVID conditions.
